Rare diseases, orphan drugs, and orphaned patients.
Scheindlin
Stanley
S
Drug Product Development and Regulatory Affairs.
D014150:Antipsychotic Agents / Q000627:therapeutic use; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007880:Legislation, Drug; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D010344:Patient Advocacy; D010868:Pimozide / Q000627:therapeutic use; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D014150:Antipsychotic Agents; D010868:Pimozide; D006220:Haloperidol